Navigation Links
New Book Out with Two Chapters on Veterinary Regenerative Medicine Written by Dr. Bob Harman, CEO for VetStem Biopharma, Now Available through Amazon
Date:1/18/2016

Dr. Bob Harman, CEO for VetStem Biopharma, was asked by the editors, the top regenerative medicine luminaries in human medicine, to write two key chapters to share the advances made in veterinary medicine with stem cell therapy. “I am honored to have been asked to contribute to such an important book,” said Dr Harman. “This information will help human stem cell companies with their quest to get products through the regulatory and research hurdles and on the market and helping patients.”

Dr. Harman has been a leader in this area for over a decade and has presented at dozens of human regenerative medicine conferences. He pulls from his biotechnology and veterinary experience to perfect the clinical application of stem cell therapy for various types of injuries, illnesses, and other healing-promoting applications. VetStem is leading in the development for regenerative medicine in the veterinary field, with over 11,000 animals treated in the last 12 years. Dr. Harman is also author on 13 peer-reviewed articles and book chapters.

The book, entitled Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies, is a unique guide to emerging stem cell technologies and the opportunities for their commercialization. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine. The book includes reviews of the very latest advances in the technology and business of stem cells used for therapy, research, and diagnostics. It identifies key challenges to the commercialization of stem cell technology and avenues to overcome problems in the pipeline. Dr Harman’s chapters cover the market for stem cell medicines for domestic and high value animals and practical approaches to stem cell medicine in the veterinary field.

The book is written by an expert team with extensive experience in the business of the applied science of stem cell research. This comprehensive volume is essential reading for researchers in cell biology, biotechnology, regenerative medicine, and tissue engineering, including scientists and professionals, looking to enter commercial biotechnology fields.

About VetStem Biopharma
VetStem Biopharma, was founded by Dr Bob Harman and is a veterinarian lead company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 12 years and over 11,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 55 issued patents in the field of regenerative medicine.

Read the full story at http://www.prweb.com/releases/2016/01/prweb13167872.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Growth Continues for SPIE Student Chapters
2. MediVet Biologics to Present University Study on Canine Stem Cells during 2016 North American Veterinary Conference
3. Peak Performance Veterinary Group and VetStem Biopharma, Announce Educational and Clinical Partnership in Support of Local Area Veterinarians
4. VetStem Biopharma and PALL Life Sciences announce a clinical research/technology distribution agreement for Pall’s Veterinary Platelet Enhancement Therapy system V-PET™
5. Parker Road Veterinary Hospital is Now Offering Stem Cell Therapy for Dogs and Cats
6. Global Animal Biotechnology Report 2015-2024 - Applications in Veterinary Medicine and Pharmaceuticals as well as Improvement in Food Production
7. Advanced Care Veterinary Services is Now Offering Stem Cell Therapy for Dogs and Cats in Conjunction with VetStem Biopharma
8. Ancon Medical Disease Screening Technology Adapted for Veterinary Medicine
9. VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour
10. MediVet Biologics adds Merritt Veterinary Supplies, Inc. as a Distribution Partner of Veterinary Stem Cell and other Biologic treatment options.
11. OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2018)... (PRWEB) , ... July 25, 2018 , ... ... Things (IoT) Systems Innovator, joined the board of the Indiana India Business Council ... and unanimously elected today by the current board of directors, McDonald joins an ...
(Date:7/24/2018)... (PRWEB) , ... July 24, 2018 , ... R3 Stem ... in Las Vegas. The treatments are offered by Double Board Certified providers, with outcomes ... mostly okay with suppressing symptoms, but have done nothing to help repair and regenerate ...
(Date:7/24/2018)... ... July 24, 2018 , ... On August 6, 2018, BioMedGPS ... Not just a pretty face, SmartTRAK 3.0’s latest improvements were inspired by ... the world’s first online and real-time data portal that specializes in providing competitive ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, a Luxembourg based ... Phase 3 clinical program in Dry Eye Disease. Under the agreement Essex Bio-Investment ... allocated towards the first Phase 3 study starting as early as Fall 2018. ...
Breaking Biology Technology:
(Date:8/9/2018)... ... 2018 , ... Plum Alley Investments, an innovative platform providing ... has invested in a sought-after $23 million Series A round for Mammoth Biosciences ... Biosciences , The biotech company is bringing to market the latest CRISPR innovations ...
(Date:8/7/2018)... ... August 07, 2018 , ... ... development, announces a new publication titled, “Synthetic Molecules for Disruption of the ... paper prominently features use of Agile R100, described as a “ field-effect transistor ...
(Date:8/1/2018)... ... August 01, 2018 , ... Dr. Asher Kimchi, Founder and Chairman of the ... 2018 IAC Awards at the 23rd World Congress on Heart Disease held in Boston, ... to receive the Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Chairman Dr. ...
Breaking Biology News(10 mins):